Next Article in Journal
Structure and Function of Membrane Proteins
Next Article in Special Issue
Low Magnesium Concentration Enforces Bone Calcium Deposition Irrespective of 1,25-Dihydroxyvitamin D3 Concentration
Previous Article in Journal
miR-145-3p Inhibits MuSCs Proliferation and Mitochondria Mass via Targeting MYBL1 in Jianzhou Big-Eared Goats
Previous Article in Special Issue
The Interactions of Magnesium Sulfate and Cromoglycate in a Rat Model of Orofacial Pain; The Role of Magnesium on Mast Cell Degranulation in Neuroinflammation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction

Department of Biomedical and Clinical Sciences, Università di Milano, Via GB Grassi 74, 20157 Milano, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(9), 8351; https://doi.org/10.3390/ijms24098351
Submission received: 29 March 2023 / Revised: 28 April 2023 / Accepted: 4 May 2023 / Published: 6 May 2023
(This article belongs to the Special Issue The Role of Mg Homeostasis in Disease)

Abstract

:
Magnesium deficiency is associated with a greater risk of developing cardiovascular diseases since this cation is fundamental in regulating vascular function. This clinical evidence is sustained by in vitro studies showing that culturing endothelial cells in low concentrations of magnesium promotes the acquisition of a pro-oxidant and pro-inflammatory phenotype. Here, we show that the increase in reactive oxygen species in endothelial cells in low-magnesium-containing medium is due to the upregulation of the pro-oxidant protein thioredoxin interacting protein (TXNIP), with a consequent accumulation of lipid droplets and increase in endothelial permeability through the downregulation and relocalization of junctional proteins. Silencing TXNIP restores the endothelial barrier and lipid content. Because (i) mitochondria serve multiple roles in shaping cell function, health and survival and (ii) mitochondria are the main intracellular stores of magnesium, it is of note that no significant alterations were detected in their morphology and dynamics in our experimental model. We conclude that TXNIP upregulation contributes to low-magnesium-induced endothelial dysfunction in vitro.

Graphical Abstract

1. Introduction

Vascular endothelial cells are fundamental gatekeepers of cardiovascular health since they regulate vessel tone, blood flow, coagulation, inflammation and smooth muscle cell proliferation [1]. Accordingly, injury or dysfunction of the endothelium leads to different diseases. Magnesium (Mg) deficiency is one of the many factors impairing endothelial function [2,3]. Mg is introduced in the diet through both food and water, and in the human body it represents the fourth most abundant mineral after calcium, potassium and sodium [2]. Intracellularly, Mg acts as a cofactor of hundreds of enzymes, participating in reactions involved in all the metabolic pathways, and it contributes to the regulation of membrane stability, regulates ion channels and serves as an intracellular signal [4,5]. Epidemiological studies have shown that poor Mg intakes are associated with a greater risk of developing cardiovascular diseases (arrhythmia, coronary heart disease, pre-eclampsia, heart failure), neurological diseases (seizures), depression and respiratory diseases [6,7,8]. In vitro, low Mg triggers endothelial dysfunction by promoting the acquisition of a pro-oxidant and pro-inflammatory phenotype, impairing the antioxidant defenses, modulating gene expression, retarding cell growth and promoting senescence [3,9,10]. In a previous work, we showed that human endothelial cells from the umbilical vein (HUVEC), a widely used model for macrovascular endothelial cells, react to 24 h of culture in low Mg with an increase in the levels of Peroxisome Proliferator Activated Receptor gamma (PPAR-γ) and its transcriptional coactivator Endothelial Differentiation-related Factor-1 (EDF-1), which promote the deposition of lipids through a reactive oxygen species (ROS)-dependent mechanism [11]. It is known that endothelial cells can store neutral lipids in lipid droplets [12], cytosolic fat storage organelles that are dynamically synthesized in response to cellular needs or different stimuli [13]. Far from being only an inert reservoir of triglycerides, lipid droplets are emerging as important regulators of different pathways. They regulate the redox status of the cells protecting them from lipotoxicity [14]. In addition, they maintain energy homeostasis, interact with mitochondria and participate in the regulation of the membrane composition. Oxidative stress, nutritional variation and energy imbalance induce their biogenesis [13].
A fundamental role of the endothelium is to maintain the barrier function, which is essential for the proper compartmentalization of the vascular and interstitial spaces. Failure to maintain barrier integrity results in the leakage of fluid and proteins from the vasculature into the interstitial space, an event involved in many diseases, particularly conditions such as sepsis that can be fatal [15]. Various pro-atherogenic stimuli increase macrovascular endothelial cell permeability through ROS overproduction and the consequent pro-inflammatory status [16]. This leads to rearrangements of cell-to-cell junctions, which facilitate the subendothelial deposition of low-density lipoproteins. Indeed, the distribution of VE-cadherin, pivotal in maintaining the endothelial barrier, is disorganized in atherosclerosis [17]. Considering that Mg deficiency has a role in atherogenesis [2,3,18,19,20], we recall a previous study demonstrating that Mg deprivation increases endothelial permeability in vitro and in vivo through the S1P1-Rac1 pathways [21]. However, no data are available about junctional proteins at the moment.
Here, we investigated how an acute severe reduction in extracellular Mg (0.1 mM Mg for 24 h) generates oxidative stress in HUVEC. We also analyzed endothelial permeability and lipid accumulation in the same experimental conditions.

2. Results

2.1. Culture in Low-Mg Medium Does Not Impact the Intracellular Mg and Calcium Levels

Human umbilical vein endothelial cells (HUVEC) were cultured in medium containing a normal (1 mM) or low (0.1 mM) concentration of extracellular Mg for 24 h to evaluate if the culture in medium containing 0.1 mM Mg might affect the intracellular concentrations of magnesium and calcium ions (Mg2+ and Ca2+). We measured free Mg2+ and Ca2+ using Mag-fura-2AM and Fura-2AM, respectively, and found no differences between HUVEC in 0.1 and 1 mM Mg. In addition, we found that the concentration of total Mg, measured with the fluorescent probe DCHQ5 [22], did not vary under the two experimental conditions (Figure 1).

2.2. Culture in Low-Mg Medium Induces Cytosolic ROS Accumulation by Upregulating TXNIP

Since low Mg concentrations are associated with ROS production [11,23,24], we investigated whether the accumulation of ROS was due to an imbalance in the levels of proteins involved in redox homeostasis. Through Western blotting, we analyzed the levels of two stress proteins also implicated in protecting against oxidative stress [25,26], i.e., Heat Shock Protein (HSP)27 and HSP70, and the levels of the pro-oxidant protein TXNIP. We found that low Mg concentration did not affect HSP27, phosphorylated (P-HSP27) or not, or HSP70 levels, while it increased TXNIP (Figure 2a). We then measured mitochondrial ROS using the fluorescent dye Mitosox and found no differences between cells cultured in 0.1 or 1.0 mM Mg (Figure 2b), thus indicating the cytosolic source of ROS. To demonstrate the role of TXNIP upregulation in low-Mg-induced accumulation of ROS, we silenced it using siRNA. qRT-PCR and Western blotting showed successful silencing (Figure 2c). Then, we measured the amount of ROS using the DCFDA probe. Figure 2d shows that silencing TXNIP reduced ROS to control levels.

2.3. Culture in Low-Mg Medium Does Not Affect Mitochondria

Because ROS excess leads to mitochondrial dysfunction [27] and Mg also regulates mitochondrial function [28], we analyzed mitochondria as follows: (i) quantification of the mitochondrial content through MitoTracker (Figure 3a); (ii) detection of the morphology of the organelles via immunofluorescence using anti-cyclophilin D (CYP D) antibodies (Figure 3b); (iii) assessment of mitochondrial dynamics (Figure 3c). We found that the mitochondrial content and morphology were not affected in low-Mg-cultured HUVEC (Figure 3a,b), in agreement with the conservation of the balance between the fission protein dynamin related protein (DRP)1, its phosphorylated forms on Serine 616 and 637 (pDRP1Ser616 and pDRP1Ser637), which are activatory and inhibitory, respectively, and the fusion protein optic atrophy (OPA)1 (Figure 3c).

2.4. Culture in Low-Mg Medium Induces the Accumulation of Lipid Droplets through TXNIP Upregulation

In a previous study, we reported that HUVEC cultured in Mg-deficient medium accumulated lipids [11]. To gain more insight into this issue, we initially measured the total amount of triglycerides and found it increased after the cells were cultured in medium containing 0.1 mM Mg for 24 h (Figure 4a). By co-staining the samples with bodipy and the lipid droplet protein Perilipin-2 (PLIN2), we visualized vesicles laden with neutral lipids and surrounded by PLIN2-enriched membranes in low-Mg-cultured HUVEC, thereby demonstrating a marked increase in lipid droplets in Mg-deficient HUVEC (Figure 4b).
We also found that TXNIP silencing prevented the accumulation of triglycerides and lipid droplets in HUVEC cultured in Mg-deficient medium (Figure 4). Silencing TXNIP in HUVEC in 1 mM Mg exerted no effect [29].

2.5. Culture in Low-Mg Medium Increases Endothelial Permeability through TXNIP Upregulation

We focused our attention on endothelial permeability, a well-known marker of endothelial function. Figure 5a shows that the cells cultured in low Mg were more permeable to fluorescein isothiocyanate-labeled albumin (FITC-BSA) than the control in 1 mM Mg. Silencing TXNIP restored normal permeability.
To explore the underlying mechanisms, we analyzed the amounts and localization of two crucial junctional proteins, Ve-cadherin (VECAD), a member of the adherens junction family, and the tight junction protein zonula occludens (ZO)-1, via Western blotting and immunofluorescence. The cells cultured in 0.1 mM Mg were characterized by lower amounts of ZO-1 and VECAD than the controls, and TXNIP silencing restored the physiological levels of the two proteins (Figure 5b). Interestingly, we noticed that the low-Mg-induced increase in TXNIP also affected the localization of both VECAD and ZO-1. Indeed, the cells cultured in 0.1 mM Mg exhibited intercellular gaps whose formation was prevented by silencing TXNIP (Figure 5c,d), in accordance with the results obtained in the permeability assay.

2.6. Low-Mg-Induced Increase in TXNIP Affects Ve-Cadherin Stability

As for VECAD, the most important player in regulating the vascular endothelial barrier function [30,31], its levels and linear organization as well as post-translational modifications are crucial to maintain the barrier function. In particular, Ve-cadherin phosphorylation on Tyr658 (P-VECAD) augments permeability [32,33,34]. Through immunofluorescence, we detected higher amounts of P-VECAD in HUVEC cultured in 0.1 mM Mg than in the control, and silencing TXNIP prevented Tyr658 phosphorylation (Figure 6).

3. Discussion

Mg has a role in maintaining endothelial integrity and function. Accordingly, in humans, Mg deficiency is linked to an increased risk of coronary heart disease [35], and this finding is explained, at least in part, by the evidence that low levels of Mg promote endothelial dysfunction [3,9,11,36], the initial step in atherogenesis. HUVEC are very sensitive to Mg deprivation. At the transcriptional level, 24 h culture in 0.1 mM Mg modulates the expression of 2728 transcripts [37], mainly involved in inflammatory responses. Accordingly, robust experimental evidence has accumulated regarding the acquisition of a pro-inflammatory, pro-atherogenic and pro-thrombotic phenotype by HUVEC cultured in Mg-deficient media [3,9,38,39,40].
In this work, we first explored the levels of intracellular Mg in HUVEC cultured in 0.1 and 1.0 mM Mg for 24 h and detected no significant differences, a finding that is corroborated by the demonstration that most mammalian cells exposed to Mg deprivation retain their basal intracellular Mg content [41]. It is feasible that the cells adapt to low Mg availability by activating pathways that maintain intracellular Mg concentrations, thus granting basal metabolic activities and membrane integrity, among others. It is the presence of several plasma membrane channels and transporters that guarantees intracellular Mg levels. As we have recently shown [42], HUVEC express the transient receptor potential cation channel subfamily M member (TRPM)7, Magnesium Transporter 1 (MagT1) and solute Carrier family 41 member 1 (SLC41A1). Since HUVEC cultured in 0.1 mM Mg medium upregulate TRPM7 [43], we propose a role for TRPM7 in maintaining intracellular Mg homeostasis in our experimental model. Additionally, free Ca2+ does not change, and this is an important issue since Mg has long been considered the physiologic calcium blocker [44].
Mg deficiency promotes oxidative stress. Here, we show that the upregulation of TXNIP is, in part, responsible for the accumulation of ROS, lipid droplets and hyperpermeability in HUVEC exposed to low Mg. Since the intracellular concentration of Mg is comparable in controls and in HUVEC cultured in Mg-deficient medium, a puzzling question remains concerning the mechanisms underlying TXNIP upregulation. Again, we hypothesize a role for TRPM7, whose levels, as just mentioned, increase in response to low extracellular Mg [43]. Indeed, TRPM7 not only transports Mg but is also a kinase that phosphorylates several substrates, thus influencing signal transduction, transcription, translation and protein stability [45]. More studies are necessary to verify if a link exists between TRPM7 upregulation and TXNIP stability. TXNIP participates in the control of the redox balance, by negatively regulating the expression and function of TRX [25,46,47]. This action explains why the upregulation of TXNIP is involved in the pathogenesis of several inflammatory disorders [48]. In vitro TXNIP is increased in hypertension-promoted endothelial dysfunction [49] and in 4-hydroxynonenal-induced endothelial senescence [50]. Therefore, it is not surprising that TXNIP inhibition alleviates H2O2-induced senescence in HUVEC [51]. Notably, TXNIP upregulation is central in driving the accumulation of lipid droplets in HUVEC exposed to high glucose [29]. Similarly, HUVEC cultured in low-Mg-containing medium for 24 h overproduce triglycerides that are then stored in lipid droplets, an event prevented by silencing TXNIP. Lipid droplets are dynamic organelles that store energy in the form of neutral lipids, but also mitigate stress because they take up toxic lipids and, therefore, protect against toxicity [12,52]. It is feasible that the increase in lipid droplets represents a common adaptive feature of metabolically stressed endothelial cells. Accordingly, lipid droplets are increased in the endothelium lining atheroma and in cultured endothelial cells exposed to high-cholesterol-containing sera [53]. Lipid droplets also curtail mitochondrial fragmentation and ROS production [54]. It is worth noting that no alterations in the mitochondrial content and dynamics were detected in HUVEC in Mg-deficient medium vs. their controls, and we hypothesize that lipid droplets might exert a protective effect. Mitochondria, the power plants of the cell, are the principal intracellular Mg stores, since one third of the total Mg is located in these organelles [55]. Mg regulates mitochondrial function [28], and dysregulated levels of mitochondrial Mg alter cellular energy metabolism [56]. We propose that 24 h culture in Mg-deficient medium does not affect the mitochondrial network and dynamics, probably because of the capacity of HUVEC to maintain cytosolic intracellular Mg homeostasis.
We also demonstrate that low extracellular Mg impairs the endothelial barrier function by altering inter-endothelial junctions, meaning that gaps form between neighboring cells. We show that Mg deficiency disrupts the distribution of VE-cadherin, the main component of endothelial adherens junctions, critically involved in the control of the endothelial barrier [30,31,57]. In HUVEC cultured in low Mg, the opening of the junction is due to the phosphorylation of Y658. Once phosphorylated, VE-cadherin is internalized and ubiquitinated [58]. Since silencing TXNIP restores endothelial permeability as well as the membrane localization of junctional proteins, we hypothesize a role of TXNIP in increasing endothelial permeability by raising ROS levels and, consequently, activating NFkB, thus inducing interleukin 1 [36], a potent inducer of vascular permeability [59].

4. Materials and Methods

4.1. Cell Culture

Human umbilical vein endothelial cells (HUVEC) were obtained from the American Type Culture Collection (ATCC, Manassas, WV, USA) and cultured in medium M199 (Euroclone, Milan, Italy) containing 10% fetal bovine serum (FBS), 1 mM l-Glutamine, 1 mM Sodium Pyruvate, 1 mM Penicillin-Streptomycin, 5 U/mL Heparin and 150 µg/mL Endothelial Cell Growth Factor on 2% gelatin-coated dishes (Euroclone). To analyze the effects of normal (1 mM) and low (0.1 mM) Mg concentrations, HUVEC were cultured in custom-made Mg-free medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with Mg sulfate (MgSO4) to reach these final concentrations.

4.2. Magnesium and Calcium Measurement

For the total intracellular Mg quantification, the DCHQ5 probe (donated by S. Iotti) was used [22]. After 24 h of treatment, HUVEC were trypsinized, collected and counted, and 10,000 cells were used for the analysis. Cells were lysed in phosphate-buffered saline (PBS) and sonicated. Then, the sample was diluted in a 1:1 MOPS (3-(N-morpholino) propanesulfonic acid): MeOH (pH 7.4) solution, and the DCHQ5 probe was added at a final concentration of 15 µM. The fluorescent signal (λexc = 360 nm, λemm = 510 nm) was detected with a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific).
Free intracellular Mg2+ and Ca2+ were measured with the fluorescent probes Mag-fura-2AM and Fura-2AM, respectively (Molecular probes, Thermo Fisher Scientific). Cells were seeded on a black 96-well plate (Greiner bio-one, Frickenhausen, Germany), and 24 h after the treatment, cells were incubated for 1 h with the respective probe (Mag-fura-2AM: 2.5 µM; Fura-2AM 10μm). The fluorescent signal was measured (Mag-fura-2AM: λexc = 335 nm, λemm = 510 nm; Fura-2AM: λexc = 340 nm, λemm = 510 nm). The experiment was performed three times in triplicate, and the results are expressed as the mean ± SD.

4.3. Western Blot

HUVEC were lysed in 10 mM Tris-HCl (pH 7.4) containing 3 mM MgCl2, 10 mM NaCl, 0.1% SDS, 0.1% Triton X-100, 0.5 mM EDTA and protein inhibitors, separated on SDS-PAGE and transferred to nitrocellulose sheets at 400 mA for 2h at 4 °C. Western blot analysis was performed using antibodies against P-HSP27, HSP27, DRP1, pDRP1Ser616, pDRP1Ser637, OPA1 (Cell Signaling Technology, Danvers, MA, USA), TXNIP, CYP D, ZO-1, VECAD (Thermo Fisher Scientific), HSP70 and Actin (Tebu Bio-Santa Cruz, Magenta, Italy), which were used as a control of loading. After extensive washing, secondary antibodies labeled with horseradish peroxidase (Amersham Pharmacia Biotech Italia, Cologno Monzese, Italy) were used. The Super-Signal chemiluminescence kit (Thermo Fisher Scientific) was used to detect the immunoreactive proteins. All the experiments were performed at least three times, and a representative blot is shown. Densitometry of the bands from three blots was performed with the software ImageLab (Bio-Rad, Hercules, CA, USA), and the results are expressed as the mean ± SD.

4.4. ROS Measurement

For the detection of ROS, HUVEC were cultured in a black 96-well plate (Greiner bio-one) and, at the end of the experiments, incubated for 30 min with 10 mM 2′-7′-dichlorofluorescein diacetate (DCFDA) solution (Thermo Fisher Scientific) to detect total intracellular ROS, or with 5 μM MitoSOX Red mitochondrial superoxide indicator (Thermo Fisher Scientific) to detect mitochondrial ROS. The dye emission was monitored (for DCFDA: λexc = 495 nm, λemm = 529 nm; for MitoSOX: λexc = 510 nm, λemm = 580 nm) using a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific). The amount of ROS production was normalized to the cell number counted after trypsinization. The results are the mean of three independent experiments performed in triplicate ± SD.

4.5. TXNIP Silencing

TXNIP was silenced using small interfering RNAs (siRNAs). Subconfluent cells were transfected using Lipofectamine RNAiMAX (Invitrogen, Thermo Fisher Scientific) combined with siRNAs targeting TXNIP (20 nmol, 5′-AAGCCGTTAGGATCCTGGCT-3′ (Qiagen, Hilden, Germany)) (0.1 + siRNA TXNIP), while non-silenced samples (0.1 + NS and 1 + NS) were transfected with a scrambled non-silencing (NS) sequence. After 6 h, the siRNA transfection medium was replaced with a culture medium for the respective treatment.

4.6. Real-Time PCR

Total RNA was extracted using the PureLink RNAMini Kit (Thermo Fisher Scientific). Single-stranded cDNA was synthesized from 1 mg RNA in a 20 µL final volume using the High-Capacity cDNA Reverse Transcription Kit with RNase inhibitor (Thermo Fisher Scientific), according to the manufacturer’s instructions. Real-time PCR was performed in triplicate using the CFX96 Real-Time PCR Detection system (Bio-Rad) with TaqMan Gene Expression Assay probes for TXNIP (Hs00197750_m1) and GAPDH (Hs99999905_m1) (Life Technologies, Thermo Fisher Scientific). The housekeeping gene GAPDH was used as an internal reference gene. Relative changes in gene expression were analyzed using the 2−ΔΔCt method. The experiment was performed in triplicate three times. Data are expressed as means ± SD.

4.7. Immunofluorescence and Confocal Imaging

To stain mitochondria and adhesion molecules, the cells were fixed in PBS containing 4% paraformaldehyde and 2% sucrose (pH 7.6), permeabilized with Triton 0.3% and incubated with antibodies anti-PLIN2 (Abcam, Cambridge, UK), CYP D, VECAD, ZO-1 and P-vecad (Thermo Fisher Scientific) overnight at 4 °C, followed by staining with an Alexa Fluor secondary antibody (Thermo Fisher Scientific). 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI, Sigma-Aldrich) was used to stain the nuclei. Finally, the cells were mounted with ProLong™ Gold Antifade Mountant (Thermo Fisher Scientific), and images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Alternatively, to label mitochondria for quantification, the cells grown on microscope glasses and treated for 24 h were incubated with medium containing 25 nM of MitoTracker Red CMXRos (Thermo Fisher Scientific) for 15 min at 37 °C, and then the fluorescence was read (λexc = 570 nm, λemm = 599 nm) using a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific). Fluorescence analysis was performed by quantifying the intensity of the staining signal using ImageJ. Colocalization analysis of two proteins was performed using the Jacop plugin of ImageJ to analyze the merging of the two colors. The results are expressed as the mean ± SD.

4.8. Triglyceride Quantification

Triglycerides were quantified using a Triglyceride Quantification Kit (Sigma-Aldrich) according to the manufacturer’s instructions. Basically, triglycerides were extracted from cell lysates and broken down into fatty acids and glycerol, which was suddenly oxidized to generate a fluorescent product (λexc = 535 nm, λemm = 590 nm). The fluorescence was measured using a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific). The results were normalized to the cell number, and are presented as the mean of three independent experiments performed in triplicate ± SD.

4.9. Bodipy Staining

For the intracellular quantification of neutral lipids, Bodipy staining and quantification were performed (Thermo Fisher Scientific). The cells were seeded on a black 96-well plate, treated for 24 h and then stained following the manufacturer’s instructions. The fluorescence was detected using a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific) (λexc = 493 nm, λemm = 503 nm). The experiment was performed in triplicate three times, and the data are expressed as the mean ± SD.

4.10. Transwell Permeability Assay

The Transwell Permeability Assay was performed in a 24-well receiver plate with individual hanging cell culture inserts (Transwell Permeable Supports, 0.4 µm micropores, Euroclone). HUVEC were seeded into the inserts and, when confluent, treated with 0.1 mM Mg + NS, 1 mM Mg + NS or 0.1 + siRNA TXNIP mM Mg for 24 h. At the end of the treatment, 1 mg/mL fluorescein isothiocyanate-labeled albumin (FITC–BSA) (Sigma–Aldrich) was added to the upper part of the transwell, and the extent of permeability was determined by measuring the fluorescence in the lower compartment. The fluorescence was detected using a Varioskan LUX Multimode Microplate Reader (Thermo Fisher Scientific) (λexc = 495 nm, λemm = 519 nm). The experiment was performed in triplicate three times, and the data are expressed as the mean ± SD.

4.11. Statistical Analysis

Data are reported as means ± SD. For the experiments with only two experimental conditions (0.1 mM and 1 mM Mg), the data were analyzed using the Student t-test method. For the experiments with three samples (0.1 mM Mg + NS, 1 mM Mg + NS and 0.1 mM Mg + siRNA TXNIP), the data were normally distributed, and they were analyzed using one-way repeated measures ANOVA. The p-values derived from the multiple pairwise comparisons were corrected using the Bonferroni method. Statistical significance was defined as a p-value of ≤0.05. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.

5. Conclusions

Acute and severe Mg deficiency upregulates TXNIP, which contributes to the generation of ROS, with a consequent increase in endothelial permeability and accumulation of triglycerides in lipid droplets. More studies are ongoing to test how HUVEC behave when chronically challenged with very low extracellular Mg concentrations.

Author Contributions

Conceptualization, J.A.M.; methodology, L.L. and G.F.; formal analysis, L.L., G.F. and J.A.M.; resources, J.A.M.; writing—original draft preparation, L.L. and G.F.; writing—review and editing, J.A.M.; funding acquisition, J.A.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

Data are openly available at Dataverse through the following link: https://dataverse.unimi.it/dataverse/txnip_magnesium, accessed on 28 April 2023.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cahill, P.A.; Redmond, E.M. Vascular endothelium—Gatekeeper of vessel health. Atherosclerosis 2016, 248, 97–109. [Google Scholar] [CrossRef]
  2. Kostov, K.; Halacheva, L. Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension. Int. J. Mol. Sci. 2018, 19, 1724. [Google Scholar] [CrossRef] [PubMed]
  3. Maier, J.A.M. Endothelial cells and magnesium: Implications in atherosclerosis. Clin. Sci. 2012, 122, 397–407. [Google Scholar] [CrossRef] [PubMed]
  4. Maier, J.A.; Castiglioni, S.; Locatelli, L.; Zocchi, M.; Mazur, A. Magnesium and inflammation: Advances and perspectives. Semin. Cell Dev. Biol. 2021, 115, 37–44. [Google Scholar] [CrossRef] [PubMed]
  5. Li, F.-Y.; Chaigne-Delalande, B.; Kanellopoulou, C.; Davis, J.C.; Matthews, H.F.; Douek, D.C.; Cohen, J.I.; Uzel, G.; Su, H.C.; Lenardo, M.J. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 2011, 475, 471–476. [Google Scholar] [CrossRef] [PubMed]
  6. Al Alawi, A.M.; Majoni, S.W.; Falhammar, H. Magnesium and Human Health: Perspectives and Research Directions. Int. J. Endocrinol. 2018, 2018, 9041694. [Google Scholar] [CrossRef]
  7. Pelczyńska, M.; Moszak, M.; Bogdański, P. The Role of Magnesium in the Pathogenesis of Metabolic Disorders. Nutrients 2022, 14, 1714. [Google Scholar] [CrossRef]
  8. Maier, J.A.M.; Locatelli, L.; Fedele, G.; Cazzaniga, A.; Mazur, A. Magnesium and the Brain: A Focus on Neuroinflammation and Neurodegeneration. Int. J. Mol. Sci. 2022, 24, 223. [Google Scholar] [CrossRef]
  9. Ferrè, S.; Baldoli, E.; Leidi, M.; Maier, J.A.M. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. Biochim. Biophys. Acta 2010, 1802, 952–958. [Google Scholar] [CrossRef]
  10. Castiglioni, S.; Cazzaniga, A.; Locatelli, L.; Maier, J.A. Burning magnesium, a sparkle in acute inflammation: Gleams from experimental models. Magnes. Res. 2017, 30, 8–15. [Google Scholar] [CrossRef]
  11. Locatelli, L.; Fedele, G.; Castiglioni, S.; Maier, J.A. Magnesium deficiency induces lipid accumulation in vascular endothelial cells via oxidative stress—The potential contribution of edf-1 and pparγ. Int. J. Mol. Sci. 2021, 22, 1050. [Google Scholar] [CrossRef]
  12. Kuo, A.; Lee, M.Y.; Sessa, W.C. Lipid Droplet Biogenesis and Function in the Endothelium. Circ. Res. 2017, 120, 1289–1297. [Google Scholar] [CrossRef] [PubMed]
  13. Jarc, E.; Petan, T. Lipid Droplets and the Management of Cellular Stress. Yale J. Biol. Med. 2019, 92, 435–452. [Google Scholar] [PubMed]
  14. Olzmann, J. Lipid Droplet Proteome Dynamics and Lipotoxicity. FASEB J. 2020, 34, 1. [Google Scholar] [CrossRef]
  15. Claesson-Welsh, L.; Dejana, E.; McDonald, D.M. Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies. Trends Mol. Med. 2021, 27, 314–331. [Google Scholar] [CrossRef]
  16. Mundi, S.; Massaro, M.; Scoditti, E.; Carluccio, M.A.; van Hinsbergh, V.W.M.; Iruela-Arispe, M.L.; De Caterina, R. Endothelial permeability, LDL deposition, and cardiovascular risk factors—A review. Cardiovasc. Res. 2018, 114, 35–52. [Google Scholar] [CrossRef]
  17. Miyazaki, T.; Taketomi, Y.; Takimoto, M.; Lei, X.-F.; Arita, S.; Kim-Kaneyama, J.; Arata, S.; Ohata, H.; Ota, H.; Murakami, M.; et al. m-Calpain induction in vascular endothelial cells on human and mouse atheromas and its roles in VE-cadherin disorganization and atherosclerosis. Circulation 2011, 124, 2522–2532. [Google Scholar] [CrossRef]
  18. Maier, J.A.M. Low magnesium and atherosclerosis: An evidence-based link. Mol. Aspects Med. 2003, 24, 137–146. [Google Scholar] [CrossRef]
  19. Sobhani, A.R.; Farshidi, H.; Azarkish, F.; Eslami, M.; Eftekhar, E.; Keshavarz, M.; Soltani, N. Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study. Clin. Pharmacol. 2020, 12, 159–169. [Google Scholar] [CrossRef]
  20. Rodríguez-Ortiz, M.E.; Gómez-Delgado, F.; Arenas de Larriva, A.P.; Canalejo, A.; Gómez-Luna, P.; Herencia, C.; López-Moreno, J.; Rodríguez, M.; López-Miranda, J.; Almadén, Y. Serum Magnesium is associated with Carotid Atherosclerosis in patients with high cardiovascular risk (CORDIOPREV Study). Sci. Rep. 2019, 9, 8013. [Google Scholar] [CrossRef]
  21. Zhu, D.; You, J.; Zhao, N.; Xu, H. Magnesium Regulates Endothelial Barrier Functions through TRPM7, MagT1, and S1P1. Adv. Sci. 2019, 6, 1901166. [Google Scholar] [CrossRef] [PubMed]
  22. Sargenti, A.; Farruggia, G.; Zaccheroni, N.; Marraccini, C.; Sgarzi, M.; Cappadone, C.; Malucelli, E.; Procopio, A.; Prodi, L.; Lombardo, M.; et al. Synthesis of a highly Mg2+-selective fluorescent probe and its application to quantifying and imaging total intracellular magnesium. Nat. Protoc. 2017, 12, 461–471. [Google Scholar] [CrossRef] [PubMed]
  23. Liu, M.; Dudley, S.C.J. Magnesium, Oxidative Stress, Inflammation, and Cardiovascular Disease. Antioxidants 2020, 9, 907. [Google Scholar] [CrossRef] [PubMed]
  24. Zheltova, A.A.; Kharitonova, M.V.; Iezhitsa, I.N.; Spasov, A.A. Magnesium deficiency and oxidative stress: An update. BioMedicine 2016, 6, 20. [Google Scholar] [CrossRef]
  25. Cazzaniga, A.; Locatelli, L.; Castiglioni, S.; Maier, J.A.M. The dynamic adaptation of primary human endothelial cells to simulated microgravity. FASEB J. 2019, 33, 5957–5966. [Google Scholar] [CrossRef]
  26. Szyller, J.; Bil-Lula, I. Heat Shock Proteins in Oxidative Stress and Ischemia/Reperfusion Injury and Benefits from Physical Exercises: A Review to the Current Knowledge. Oxid. Med. Cell. Longev. 2021, 2021, 6678457. [Google Scholar] [CrossRef]
  27. Kowaltowski, A.J.; Vercesi, A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 1999, 26, 463–471. [Google Scholar] [CrossRef]
  28. Pilchova, I.; Klacanova, K.; Tatarkova, Z.; Kaplan, P.; Racay, P. The Involvement of Mg2+ in Regulation of Cellular and Mitochondrial Functions. Oxid. Med. Cell. Longev. 2017, 2017, 6797460. [Google Scholar] [CrossRef]
  29. Vestweber, D.; Winderlich, M.; Cagna, G.; Nottebaum, A.F. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 2009, 19, 8–15. [Google Scholar] [CrossRef]
  30. Giannotta, M.; Trani, M.; Dejana, E. VE-cadherin and endothelial adherens junctions: Active guardians of vascular integrity. Dev. Cell 2013, 26, 441–454. [Google Scholar] [CrossRef]
  31. Garrett, J.P.; Lowery, A.M.; Adam, A.P.; Kowalczyk, A.P.; Vincent, P.A. Regulation of endothelial barrier function by p120-catenin∙VE-cadherin interaction. Mol. Biol. Cell 2017, 28, 85–97. [Google Scholar] [CrossRef]
  32. Hatanaka, K.; Simons, M.; Murakami, M. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am. J. Physiol. Heart Circ. Physiol. 2011, 300, H162–H172. [Google Scholar] [CrossRef] [PubMed]
  33. Gong, H.; Gao, X.; Feng, S.; Siddiqui, M.R.; Garcia, A.; Bonini, M.G.; Komarova, Y.; Vogel, S.M.; Mehta, D.; Malik, A.B. Evidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherin. J. Exp. Med. 2014, 211, 579–591. [Google Scholar] [CrossRef]
  34. Jiang, L.; He, P.; Chen, J.; Liu, Y.; Liu, D.; Qin, G.; Tan, N. Magnesium Levels in Drinking Water and Coronary Heart Disease Mortality Risk: A Meta-Analysis. Nutrients 2016, 8, 5. [Google Scholar] [CrossRef]
  35. Maier, J.A.M.; Malpuech-Brugère, C.; Zimowska, W.; Rayssiguier, Y.; Mazur, A. Low magnesium promotes endothelial cell dysfunction: Implications for atherosclerosis, inflammation and thrombosis. Biochim. Biophys. Acta—Mol. Basis Dis. 2004, 1689, 13–21. [Google Scholar] [CrossRef] [PubMed]
  36. Almousa, L.A.; Salter, A.M.; Castellanos, M.; May, S.T.; Langley-Evans, S.C. The Response of the Human Umbilical Vein Endothelial Cell Transcriptome to Variation in Magnesium Concentration. Nutrients 2022, 14, 3586. [Google Scholar] [CrossRef] [PubMed]
  37. Mazur, A.; Maier, J.A.M.; Rock, E.; Gueux, E.; Nowacki, W.; Rayssiguier, Y. Magnesium and the inflammatory response: Potential physiopathological implications. Arch. Biochem. Biophys. 2007, 458, 48–56. [Google Scholar] [CrossRef]
  38. Almousa, L.A.; Salter, A.M.; Langley-Evans, S.C. Varying magnesium concentration elicits changes in inflammatory response in human umbilical vein endothelial cells (HUVECs). Magnes. Res. 2018, 31, 99–109. [Google Scholar] [CrossRef]
  39. Liao, F.; Folsom, A.R.; Brancati, F.L. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 1998, 136, 480–490. [Google Scholar] [CrossRef]
  40. Romani, A.M.P. Cellular magnesium homeostasis. Arch. Biochem. Biophys. 2011, 512, 1–23. [Google Scholar] [CrossRef]
  41. Castiglioni, S.; Locatelli, L.; Fedele, G.; Cazzaniga, A.; Malucelli, E.; Iotti, S.; Maier, J.A. The Interplay between TRPM7 and MagT1 in Maintaining Endothelial Magnesium Homeostasis. Membranes 2023, 13, 286. [Google Scholar] [CrossRef] [PubMed]
  42. Baldoli, E.; Castiglioni, S.; Maier, J.A.M. Regulation and function of TRPM7 in human endothelial cells: TRPM7 as a potential novel regulator of endothelial function. PLoS ONE 2013, 8, e59891. [Google Scholar] [CrossRef] [PubMed]
  43. Touyz, R.M. Magnesium supplementation as an adjuvant to synthetic calcium channel antagonists in the treatment of hypertension. Med. Hypotheses 1991, 36, 140–141. [Google Scholar] [CrossRef] [PubMed]
  44. Zou, Z.-G.; Rios, F.J.; Montezano, A.C.; Touyz, R.M. TRPM7, Magnesium, and Signaling. Int. J. Mol. Sci. 2019, 20, 1877. [Google Scholar] [CrossRef] [PubMed]
  45. Pan, M.; Zhang, F.; Qu, K.; Liu, C.; Zhang, J. TXNIP: A Double-Edged Sword in Disease and Therapeutic Outlook. Oxid. Med. Cell. Longev. 2022, 2022, 7805115. [Google Scholar] [CrossRef]
  46. Yoshihara, E.; Masaki, S.; Matsuo, Y.; Chen, Z.; Tian, H.; Yodoi, J. Thioredoxin/Txnip: Redoxisome, as a redox switch for the pathogenesis of diseases. Front. Immunol. 2014, 4, 514. [Google Scholar] [CrossRef]
  47. Qayyum, N.; Haseeb, M.; Kim, M.S.; Choi, S. Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook. Int. J. Mol. Sci. 2021, 22, 2754. [Google Scholar] [CrossRef]
  48. Wang, R.; Guo, Y.; Li, L.; Luo, M.; Peng, L.; Lv, D.; Cheng, Z.; Xue, Q.; Wang, L.; Huang, J. Role of thioredoxin-interacting protein in mediating endothelial dysfunction in hypertension. Genes Dis. 2022, 9, 753–765. [Google Scholar] [CrossRef]
  49. Riahi, Y.; Kaiser, N.; Cohen, G.; Abd-Elrahman, I.; Blum, G.; Shapira, O.M.; Koler, T.; Simionescu, M.; Sima, A.V.; Zarkovic, N.; et al. Foam cell-derived 4-hydroxynonenal induces endothelial cell senescence in a TXNIP-dependent manner. J. Cell. Mol. Med. 2015, 19, 1887–1899. [Google Scholar] [CrossRef]
  50. Wu, G.; Li, S.; Qu, G.; Hua, J.; Zong, J.; Li, X.; Xu, F. Genistein alleviates H2O2-induced senescence of human umbilical vein endothelial cells via regulating the TXNIP/NLRP3 axis. Pharm. Biol. 2021, 59, 1388–1401. [Google Scholar] [CrossRef]
  51. Scrimieri, R.; Cazzaniga, A.; Castiglioni, S.; Maier, J.A.M. Vitamin D Prevents High Glucose-Induced Lipid Droplets Accumulation in Cultured Endothelial Cells: The Role of Thioredoxin Interacting Protein. Biomedicines 2021, 9, 1874. [Google Scholar] [CrossRef] [PubMed]
  52. Welte, M.A.; Gould, A.P. Lipid droplet functions beyond energy storage. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2017, 1862, 1260–1272. [Google Scholar] [CrossRef] [PubMed]
  53. Simionescu, M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 266–274. [Google Scholar] [CrossRef] [PubMed]
  54. Kovacs, M.; Geltinger, F.; Verwanger, T.; Weiss, R.; Richter, K.; Rinnerthaler, M. Lipid Droplets Protect Aging Mitochondria and Thus Promote Lifespan in Yeast Cells. Front. cell Dev. Biol. 2021, 9, 774985. [Google Scholar] [CrossRef] [PubMed]
  55. Killilea, D.W.; Killilea, A.N. Mineral requirements for mitochondrial function: A connection to redox balance and cellular differentiation. Free Radic. Biol. Med. 2022, 182, 182–191. [Google Scholar] [CrossRef] [PubMed]
  56. Yamanaka, R.; Tabata, S.; Shindo, Y.; Hotta, K.; Suzuki, K.; Soga, T.; Oka, K. Mitochondrial Mg2+ homeostasis decides cellular energy metabolism and vulnerability to stress. Sci. Rep. 2016, 6, 30027. [Google Scholar] [CrossRef] [PubMed]
  57. Gavard, J. Endothelial permeability and VE-cadherin: A wacky comradeship. Cell Adh. Migr. 2014, 8, 158–164. [Google Scholar] [CrossRef]
  58. Sidibé, A.; Imhof, B.A. VE-cadherin phosphorylation decides: Vascular permeability or diapedesis. Nat. Immunol. 2014, 15, 215–217. [Google Scholar] [CrossRef]
  59. Fahey, E.; Doyle, S.L. IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis. Front. Immunol. 2019, 10, 1426. [Google Scholar] [CrossRef]
Figure 1. Mg deficiency does not modulate intracellular Ca and Mg levels. In HUVEC cultured for 24 h in 0.1 (low) or 1 (physiological) mM Mg, we measured (a) free Mg2+ using Mag-fura-2AM, (b) free Ca2+ using Fura-2AM and (c) total Mg using the fluorescent probe DCHQ5. The experiments were performed three times in triplicate, and the data are presented as the mean ± standard deviation (SD).
Figure 1. Mg deficiency does not modulate intracellular Ca and Mg levels. In HUVEC cultured for 24 h in 0.1 (low) or 1 (physiological) mM Mg, we measured (a) free Mg2+ using Mag-fura-2AM, (b) free Ca2+ using Fura-2AM and (c) total Mg using the fluorescent probe DCHQ5. The experiments were performed three times in triplicate, and the data are presented as the mean ± standard deviation (SD).
Ijms 24 08351 g001
Figure 2. Mg deficiency alters the redox balance in HUVEC, and TXNIP silencing prevents ROS accumulation. (a) Western blots were performed on protein lysates of HUVEC cultured for 24 h in 0.1 or 1 mM Mg using antibodies against P-HSP27, HSP27, HSP70 and TXNIP. Anti-β-actin antibodies were used as a control of equal loading. A representative blot of three independent experiments is shown. Densitometry of the bands was performed with the software ImageLab, and the results are expressed as the fold change compared to the 1 mM control ± SD. (b) Mitochondrial ROS were analyzed using the fluorescent probe Mitosox. The results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. (c) Real-time PCR and Western blotting were performed on HUVEC cultured for 24 h in 0.1 mM Mg + NS (non-silencing siRNA), 1 mM Mg + NS and 0.1 mM Mg + siRNA TXNIP. For the real-time PCR, TaqMan Gene Expression Assay probes for TXNIP and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used. The housekeeping gene GAPDH was used as an internal reference gene. Relative changes in gene expression were analyzed using the 2−ΔΔCt method. Western blots were performed using antibodies against TXNIP. Anti-β-actin antibodies were used as a control of equal loading. A representative blot is shown. The experiment was performed in triplicate three times. Data are expressed as means ± SD. (d) ROS content was measured using the DCFDA probe (λexc = 495 nm, λemm = 529 nm), and the results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Figure 2. Mg deficiency alters the redox balance in HUVEC, and TXNIP silencing prevents ROS accumulation. (a) Western blots were performed on protein lysates of HUVEC cultured for 24 h in 0.1 or 1 mM Mg using antibodies against P-HSP27, HSP27, HSP70 and TXNIP. Anti-β-actin antibodies were used as a control of equal loading. A representative blot of three independent experiments is shown. Densitometry of the bands was performed with the software ImageLab, and the results are expressed as the fold change compared to the 1 mM control ± SD. (b) Mitochondrial ROS were analyzed using the fluorescent probe Mitosox. The results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. (c) Real-time PCR and Western blotting were performed on HUVEC cultured for 24 h in 0.1 mM Mg + NS (non-silencing siRNA), 1 mM Mg + NS and 0.1 mM Mg + siRNA TXNIP. For the real-time PCR, TaqMan Gene Expression Assay probes for TXNIP and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used. The housekeeping gene GAPDH was used as an internal reference gene. Relative changes in gene expression were analyzed using the 2−ΔΔCt method. Western blots were performed using antibodies against TXNIP. Anti-β-actin antibodies were used as a control of equal loading. A representative blot is shown. The experiment was performed in triplicate three times. Data are expressed as means ± SD. (d) ROS content was measured using the DCFDA probe (λexc = 495 nm, λemm = 529 nm), and the results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Ijms 24 08351 g002
Figure 3. Mitochondrial morphology and dynamics in HUVEC cultured in 0.1 or 1 mM Mg for 24 h. (a) Mitochondrial content was measured using the fluorescent probe MitoTracker (λexc = 570 nm, λemm = 599 nm). The results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. (b) Immunofluorescence was performed on HUVEC using anti-CYP D antibodies (green). 4′,6-Diamidino-2-phenylindole (DAPI) (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Scale bar: 20 µm. (c) Western blots were performed using antibodies against DRP1, pDRP1Ser616, pDRP1Ser637, OPA1 and CYP D. Anti-β-actin antibodies were used as a control of equal loading. A representative blot of three independent experiments is shown. Densitometry of the bands was performed with the software ImageLab, and the results are expressed as the fold change compared to the 1 mM control ± SD.
Figure 3. Mitochondrial morphology and dynamics in HUVEC cultured in 0.1 or 1 mM Mg for 24 h. (a) Mitochondrial content was measured using the fluorescent probe MitoTracker (λexc = 570 nm, λemm = 599 nm). The results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. (b) Immunofluorescence was performed on HUVEC using anti-CYP D antibodies (green). 4′,6-Diamidino-2-phenylindole (DAPI) (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Scale bar: 20 µm. (c) Western blots were performed using antibodies against DRP1, pDRP1Ser616, pDRP1Ser637, OPA1 and CYP D. Anti-β-actin antibodies were used as a control of equal loading. A representative blot of three independent experiments is shown. Densitometry of the bands was performed with the software ImageLab, and the results are expressed as the fold change compared to the 1 mM control ± SD.
Ijms 24 08351 g003
Figure 4. Low Mg medium-induced accumulation of lipid droplets is linked to the upregulation of TXNIP. (a) Triglyceride quantification was performed on HUVEC cultured for 24 h in 0.1 mM Mg + NS, 1 mM Mg + NS or 0.1 mM of Mg + siRNA TXNIP. Data are expressed as nmol of triglycerides. The results are the mean of three separate experiments in triplicate ± SD. (b) Confocal microscopy was performed on HUVEC using the bodipy probe (green) and antibodies against PLIN-2 (red). The merging of the colors is shown in yellow. DAPI (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope and zoomed. Scale bar: 10 µm. (c) Lipids were measured using the bodipy probe (λexc = 493 nm, λemm = 503 nm), and the results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Figure 4. Low Mg medium-induced accumulation of lipid droplets is linked to the upregulation of TXNIP. (a) Triglyceride quantification was performed on HUVEC cultured for 24 h in 0.1 mM Mg + NS, 1 mM Mg + NS or 0.1 mM of Mg + siRNA TXNIP. Data are expressed as nmol of triglycerides. The results are the mean of three separate experiments in triplicate ± SD. (b) Confocal microscopy was performed on HUVEC using the bodipy probe (green) and antibodies against PLIN-2 (red). The merging of the colors is shown in yellow. DAPI (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope and zoomed. Scale bar: 10 µm. (c) Lipids were measured using the bodipy probe (λexc = 493 nm, λemm = 503 nm), and the results are expressed as the mean fluorescence of three independent experiments performed in triplicate ± SD. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Ijms 24 08351 g004
Figure 5. Low-Mg medium increases endothelial permeability through the upregulation of TXNIP. (a) Permeability was measured using the transwell method on HUVEC cultured in 0.1 mM Mg + NS, 1 mM Mg + NS or 0.1 + siRNA TXNIP mM Mg for 24 h. The data are expressed as the percentage vs. 1 mM control ± SD. (b) Western blots were performed using antibodies against VECAD and ZO-1. Anti-β-actin antibodies were used as a control of equal loading. A representative blot of three independent experiments is shown. Densitometry of the bands was performed with the software ImageLab, and the results are expressed as the fold change compared to the control (1 mM Mg + NS) ± SD. (c,d) Immunofluorescence was performed on HUVEC using antibodies against VECAD (c, green) and ZO-1 (d, red). DAPI (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Scale bar: 20 µm. White arrows highlight gaps between cells. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Figure 5. Low-Mg medium increases endothelial permeability through the upregulation of TXNIP. (a) Permeability was measured using the transwell method on HUVEC cultured in 0.1 mM Mg + NS, 1 mM Mg + NS or 0.1 + siRNA TXNIP mM Mg for 24 h. The data are expressed as the percentage vs. 1 mM control ± SD. (b) Western blots were performed using antibodies against VECAD and ZO-1. Anti-β-actin antibodies were used as a control of equal loading. A representative blot of three independent experiments is shown. Densitometry of the bands was performed with the software ImageLab, and the results are expressed as the fold change compared to the control (1 mM Mg + NS) ± SD. (c,d) Immunofluorescence was performed on HUVEC using antibodies against VECAD (c, green) and ZO-1 (d, red). DAPI (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Scale bar: 20 µm. White arrows highlight gaps between cells. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
Ijms 24 08351 g005
Figure 6. Low-Mg medium induces the phosphorylation of Ve-cadherin in a TXNIP-dependent fashion. Immunofluorescence was performed on HUVEC using antibodies against VECAD and P-VECAD, which were then stained with an Alexa Fluor 488 (green) or 546 (red) secondary antibody, respectively. DAPI (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Scale bar: 20 µm. The quantification of the fluorescence of P-VECAD staining (left panel) and of the merging of the green/red fluorescence (right panel) is shown below the immunofluorescence. The data are expressed as the mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.
Figure 6. Low-Mg medium induces the phosphorylation of Ve-cadherin in a TXNIP-dependent fashion. Immunofluorescence was performed on HUVEC using antibodies against VECAD and P-VECAD, which were then stained with an Alexa Fluor 488 (green) or 546 (red) secondary antibody, respectively. DAPI (blue) was used to stain the nuclei. Images were acquired using a 40× objective in oil with an SP8 Leica confocal microscope. Scale bar: 20 µm. The quantification of the fluorescence of P-VECAD staining (left panel) and of the merging of the green/red fluorescence (right panel) is shown below the immunofluorescence. The data are expressed as the mean ± SD. ** p ≤ 0.01; *** p ≤ 0.001.
Ijms 24 08351 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Locatelli, L.; Fedele, G.; Maier, J.A. The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction. Int. J. Mol. Sci. 2023, 24, 8351. https://doi.org/10.3390/ijms24098351

AMA Style

Locatelli L, Fedele G, Maier JA. The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction. International Journal of Molecular Sciences. 2023; 24(9):8351. https://doi.org/10.3390/ijms24098351

Chicago/Turabian Style

Locatelli, Laura, Giorgia Fedele, and Jeanette A. Maier. 2023. "The Role of Txnip in Mediating Low-Magnesium-Driven Endothelial Dysfunction" International Journal of Molecular Sciences 24, no. 9: 8351. https://doi.org/10.3390/ijms24098351

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop